US Stock MarketDetailed Quotes

AKBA Akebia Therapeutics

Watchlist
  • 1.8800
  • +0.0300+1.62%
Trading Dec 31 11:21 ET
410.18MMarket Cap-8.55P/E (TTM)

Akebia Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
6.59%-6.7M
-377.38%-10.07M
-10.80%-19.43M
68.03%-23.38M
95.78%-2.31M
-121.20%-7.17M
111.84%3.63M
18.88%-17.54M
71.08%-73.15M
12.94%-54.68M
Net income from continuing operations
-38.30%-20.04M
23.20%-8.58M
33.08%-17.99M
44.89%-51.93M
110.11%614K
73.22%-14.49M
-139.40%-11.17M
56.94%-26.88M
66.59%-94.23M
91.31%-6.07M
Operating gains losses
--856K
---2.33M
--423K
-16.21%-760K
----
----
----
----
-9.00%-654K
--0
Depreciation and amortization
-0.35%9.37M
0.03%9.41M
-0.36%9.38M
-0.19%37.63M
-0.16%9.4M
-0.18%9.41M
-0.20%9.41M
-0.20%9.41M
-0.72%37.7M
-0.36%9.42M
Other non cash items
1,961.48%7.78M
305.84%2.54M
238.79%952K
102.40%1.5M
103.78%2.87M
-102.86%-418K
45.15%-1.23M
-69.85%281K
-264.98%-62.62M
-552.15%-75.91M
Change In working capital
-82.00%-7.66M
-576.86%-13.64M
-376.92%-15.15M
-1,336.38%-20.73M
-200.28%-16.21M
-107.27%-4.21M
103.80%2.86M
-114.93%-3.18M
98.63%-1.44M
82.94%-5.4M
-Change in receivables
20.36%-2.41M
-273.96%-3.15M
-41.21%12.67M
-91.20%994K
1.86%-16.7M
-105.14%-3.02M
94.97%-841K
257.24%21.55M
147.02%11.3M
-1,329.83%-17.02M
-Change in inventory
65.72%-545K
-528.78%-14.93M
-160.35%-4.43M
-113.32%-2.54M
-148.18%-11.78M
-58.52%-1.59M
293.33%3.48M
240.02%7.35M
176.51%19.09M
136.59%24.45M
-Change in prepaid assets
134.12%5.52M
-142.48%-130K
-80.86%1.41M
1,019.00%11.84M
120.55%1.8M
-74.46%2.36M
103.62%306K
-18.19%7.38M
105.67%1.06M
-237.38%-8.74M
-Change in payables and accrued expense
-177.38%-6.16M
171.35%7.29M
33.94%-22.55M
58.18%-15.27M
235.39%8.22M
174.49%7.96M
110.61%2.69M
-1,063.98%-34.13M
-7.95%-36.5M
107.21%2.45M
-Change in other current assets
107.53%173K
134.76%1.07M
78.20%-613K
75.80%-1.36M
125.56%6.81M
-120.86%-2.3M
-145.63%-3.06M
-185.29%-2.81M
31.54%-5.62M
-105.95%-26.65M
-Change in other current liabilities
44.27%-4.24M
-1,167.35%-3.11M
-290.44%-2.33M
-332.21%-10.65M
-125.83%-4.56M
-35.19%-7.61M
106.01%291K
147.53%1.22M
105.83%4.59M
1,570.17%17.64M
-Change in other working capital
----
----
118.59%695K
-180.32%-3.74M
--0
--0
--0
-111.19%-3.74M
155.57%4.65M
293.66%2.47M
Cash from discontinued investing activities
Operating cash flow
6.59%-6.7M
-377.38%-10.07M
-10.80%-19.43M
68.03%-23.38M
95.78%-2.31M
-121.20%-7.17M
111.84%3.63M
18.88%-17.54M
71.08%-73.15M
12.94%-54.68M
Investing cash flow
Cash flow from continuing investing activities
-2K
0
0
0
-100.29%-114K
0
Net PPE purchase and sale
---2K
----
----
--0
--0
--0
----
----
-93.22%-114K
--0
Cash from discontinued investing activities
Investing cash flow
---2K
---29K
--0
--0
--0
--0
--0
--0
-100.29%-114K
--0
Financing cash flow
Cash flow from continuing financing activities
2,346.00%1.22M
195.50%7.64M
215.71%18.48M
-272.67%-25.21M
-128,900.00%-1.29M
100.15%50K
-88,788.89%-8M
-133.58%-15.97M
-89.08%14.6M
-100.02%-1K
Net issuance payments of debt
--0
195.33%7.63M
101.71%274K
3.03%-32M
---8M
--0
---8M
---16M
---33M
--0
Net common stock issuance
3,390.00%1.75M
--750K
53,017.65%18.06M
-9.80%6.79M
671,000.00%6.71M
-20.63%50K
--0
-99.55%34K
-91.53%7.53M
-100.02%-1K
Proceeds from stock option exercised by employees
--0
--14K
--141K
-98.51%1K
--1K
--0
--0
--0
--67K
--0
Net other financing activities
---522K
----
----
----
----
----
----
----
-10.68%40M
--0
Cash from discontinued financing activities
Financing cash flow
2,346.00%1.22M
195.50%7.64M
215.71%18.48M
-272.67%-25.21M
-128,900.00%-1.29M
100.15%50K
-88,788.89%-8M
-133.58%-15.97M
-89.08%14.6M
-100.02%-1K
Net cash flow
Beginning cash position
-25.55%41.17M
-26.89%43.62M
-52.15%44.58M
-38.64%93.17M
-67.41%48.18M
-62.38%55.29M
-66.41%59.67M
-38.64%93.17M
-34.31%151.84M
-29.34%147.85M
Current changes in cash
23.09%-5.47M
43.83%-2.46M
97.14%-957K
17.18%-48.59M
93.42%-3.6M
-919.93%-7.12M
85.75%-4.37M
-229.81%-33.5M
26.01%-58.67M
4.75%-54.68M
End cash Position
-25.91%35.69M
-25.55%41.17M
-26.89%43.62M
-52.15%44.58M
-52.15%44.58M
-67.41%48.18M
-62.38%55.29M
-66.41%59.67M
-38.64%93.17M
-38.64%93.17M
Free cash flow
6.56%-6.7M
-378.18%-10.1M
-10.80%-19.43M
68.08%-23.38M
95.78%-2.31M
-121.20%-7.17M
111.84%3.63M
19.31%-17.54M
71.04%-73.27M
12.94%-54.68M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
--
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 6.59%-6.7M-377.38%-10.07M-10.80%-19.43M68.03%-23.38M95.78%-2.31M-121.20%-7.17M111.84%3.63M18.88%-17.54M71.08%-73.15M12.94%-54.68M
Net income from continuing operations -38.30%-20.04M23.20%-8.58M33.08%-17.99M44.89%-51.93M110.11%614K73.22%-14.49M-139.40%-11.17M56.94%-26.88M66.59%-94.23M91.31%-6.07M
Operating gains losses --856K---2.33M--423K-16.21%-760K-----------------9.00%-654K--0
Depreciation and amortization -0.35%9.37M0.03%9.41M-0.36%9.38M-0.19%37.63M-0.16%9.4M-0.18%9.41M-0.20%9.41M-0.20%9.41M-0.72%37.7M-0.36%9.42M
Other non cash items 1,961.48%7.78M305.84%2.54M238.79%952K102.40%1.5M103.78%2.87M-102.86%-418K45.15%-1.23M-69.85%281K-264.98%-62.62M-552.15%-75.91M
Change In working capital -82.00%-7.66M-576.86%-13.64M-376.92%-15.15M-1,336.38%-20.73M-200.28%-16.21M-107.27%-4.21M103.80%2.86M-114.93%-3.18M98.63%-1.44M82.94%-5.4M
-Change in receivables 20.36%-2.41M-273.96%-3.15M-41.21%12.67M-91.20%994K1.86%-16.7M-105.14%-3.02M94.97%-841K257.24%21.55M147.02%11.3M-1,329.83%-17.02M
-Change in inventory 65.72%-545K-528.78%-14.93M-160.35%-4.43M-113.32%-2.54M-148.18%-11.78M-58.52%-1.59M293.33%3.48M240.02%7.35M176.51%19.09M136.59%24.45M
-Change in prepaid assets 134.12%5.52M-142.48%-130K-80.86%1.41M1,019.00%11.84M120.55%1.8M-74.46%2.36M103.62%306K-18.19%7.38M105.67%1.06M-237.38%-8.74M
-Change in payables and accrued expense -177.38%-6.16M171.35%7.29M33.94%-22.55M58.18%-15.27M235.39%8.22M174.49%7.96M110.61%2.69M-1,063.98%-34.13M-7.95%-36.5M107.21%2.45M
-Change in other current assets 107.53%173K134.76%1.07M78.20%-613K75.80%-1.36M125.56%6.81M-120.86%-2.3M-145.63%-3.06M-185.29%-2.81M31.54%-5.62M-105.95%-26.65M
-Change in other current liabilities 44.27%-4.24M-1,167.35%-3.11M-290.44%-2.33M-332.21%-10.65M-125.83%-4.56M-35.19%-7.61M106.01%291K147.53%1.22M105.83%4.59M1,570.17%17.64M
-Change in other working capital --------118.59%695K-180.32%-3.74M--0--0--0-111.19%-3.74M155.57%4.65M293.66%2.47M
Cash from discontinued investing activities
Operating cash flow 6.59%-6.7M-377.38%-10.07M-10.80%-19.43M68.03%-23.38M95.78%-2.31M-121.20%-7.17M111.84%3.63M18.88%-17.54M71.08%-73.15M12.94%-54.68M
Investing cash flow
Cash flow from continuing investing activities -2K000-100.29%-114K0
Net PPE purchase and sale ---2K----------0--0--0---------93.22%-114K--0
Cash from discontinued investing activities
Investing cash flow ---2K---29K--0--0--0--0--0--0-100.29%-114K--0
Financing cash flow
Cash flow from continuing financing activities 2,346.00%1.22M195.50%7.64M215.71%18.48M-272.67%-25.21M-128,900.00%-1.29M100.15%50K-88,788.89%-8M-133.58%-15.97M-89.08%14.6M-100.02%-1K
Net issuance payments of debt --0195.33%7.63M101.71%274K3.03%-32M---8M--0---8M---16M---33M--0
Net common stock issuance 3,390.00%1.75M--750K53,017.65%18.06M-9.80%6.79M671,000.00%6.71M-20.63%50K--0-99.55%34K-91.53%7.53M-100.02%-1K
Proceeds from stock option exercised by employees --0--14K--141K-98.51%1K--1K--0--0--0--67K--0
Net other financing activities ---522K-----------------------------10.68%40M--0
Cash from discontinued financing activities
Financing cash flow 2,346.00%1.22M195.50%7.64M215.71%18.48M-272.67%-25.21M-128,900.00%-1.29M100.15%50K-88,788.89%-8M-133.58%-15.97M-89.08%14.6M-100.02%-1K
Net cash flow
Beginning cash position -25.55%41.17M-26.89%43.62M-52.15%44.58M-38.64%93.17M-67.41%48.18M-62.38%55.29M-66.41%59.67M-38.64%93.17M-34.31%151.84M-29.34%147.85M
Current changes in cash 23.09%-5.47M43.83%-2.46M97.14%-957K17.18%-48.59M93.42%-3.6M-919.93%-7.12M85.75%-4.37M-229.81%-33.5M26.01%-58.67M4.75%-54.68M
End cash Position -25.91%35.69M-25.55%41.17M-26.89%43.62M-52.15%44.58M-52.15%44.58M-67.41%48.18M-62.38%55.29M-66.41%59.67M-38.64%93.17M-38.64%93.17M
Free cash flow 6.56%-6.7M-378.18%-10.1M-10.80%-19.43M68.08%-23.38M95.78%-2.31M-121.20%-7.17M111.84%3.63M19.31%-17.54M71.04%-73.27M12.94%-54.68M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion------------
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Ecopetrol
EC
+2.99%
Petroleo Brasileiro SA Petrobras
PBR
+1.38%
KB Home
KBH
+0.64%
Vale SA
VALE
+0.61%
D.R. Horton
DHI
+0.43%

Unlock the Full List